PD-1 inhibitor in combination with fruquintinib therapy for initial unresectable colorectal cancer: A case report

BACKGROUND: PD-1 inhibitors in combination with fruquintinib have not previously been reported as neoadjuvant therapy for patients with colorectal cancer. In this case report, the combination of a PD-1 inhibitor and fruquintinib demonstrated good efficacy in patients with MSI-H colorectal cancer. CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong-Qiang, Huang, Chang-Zhi, Wu, Jing-Yu, Wang, Zhen-Ling, Shao, Yu, Fu, Zan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125291/
https://www.ncbi.nlm.nih.gov/pubmed/35663084
http://dx.doi.org/10.12998/wjcc.v10.i14.4669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125291/
https://www.ncbi.nlm.nih.gov/pubmed/35663084
http://dx.doi.org/10.12998/wjcc.v10.i14.4669

Ejemplares similares